<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">Diabetic neuropathy</z:e> is a neurological complication of <z:mp ids='MP_0002055'>diabetes</z:mp> that causes significant morbidity and, because of the <z:hpo ids='HP_0001513'>obesity</z:hpo>-driven rise in incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, is becoming a major international health problem </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> phenotype is abnormal in sensory neurons in <z:mp ids='MP_0002055'>diabetes</z:mp> and may contribute to the etiology of <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> where a distal dying-back neurodegenerative process is a key component contributing to fiber loss </plain></SENT>
<SENT sid="2" pm="."><plain>This review summarizes the major features of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction in neurons and Schwann cells in human diabetic patients and in experimental animal models (primarily exhibiting type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>) </plain></SENT>
<SENT sid="3" pm="."><plain>This article attempts to relate these findings to the development of critical neuropathological hallmarks of the disease </plain></SENT>
<SENT sid="4" pm="."><plain>Recent work reveals that <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in <z:mp ids='MP_0002055'>diabetes</z:mp> triggers nutrient excess in neurons that, in turn, mediates a phenotypic change in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> biology through alteration of the <z:chebi fb="47" ids="16027,28971">AMP</z:chebi>-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor γ coactivator-1α (<z:chebi fb="6" ids="26336">PGC</z:chebi>-1α) signaling axis </plain></SENT>
<SENT sid="5" pm="."><plain>This vital energy sensing metabolic pathway modulates <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function, biogenesis and regeneration </plain></SENT>
<SENT sid="6" pm="."><plain>The bioenergetic phenotype of mitochondria in diabetic neurons is aberrant due to deleterious alterations in expression and activity of respiratory chain components as a direct consequence of abnormal AMPK/<z:chebi fb="6" ids="26336">PGC</z:chebi>-1α signaling </plain></SENT>
<SENT sid="7" pm="."><plain>Utilization of innovative respirometry equipment to analyze <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function of cultured adult sensory neurons from diabetic rodents shows that the outcome for cellular bioenergetics is a reduced adaptability to fluctuations in ATP demand </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:mp ids='MP_0002055'>diabetes</z:mp>-induced maladaptive process is hypothesized to result in exhaustion of the ATP supply in the distal nerve compartment and induction of nerve fiber dissolution </plain></SENT>
<SENT sid="9" pm="."><plain>The role of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction in the etiology of <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> is compared with other types of <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> with a distal dying-back pathology such as Friedreich <z:hpo ids='HP_0001251'>ataxia</z:hpo>, <z:e sem="disease" ids="C0007959" disease_type="Disease or Syndrome" abbrv="">Charcot-Marie-Tooth disease</z:e> type 2 and human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus-associated distal-symmetric <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> </plain></SENT>
</text></document>